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FLRenal ﬁbrosis is the common anatomical feature underlying the progression of chronic kidney disease,
a leading cause of morbidity and mortality worldwide. In a previous study, we demonstrated that
during development of renal ﬁbrosis in a rat model of unilateral ureteric obstruction, calreticulin
(CRT) is up-regulated in tubular epithelial cells (TECs). In the present study, we used in vitro and
in vivo approaches to examine the role of CRT in TECs and its contribution to the progression of
ﬁbrosis. In cultured renal TECs, CRT overexpression induced acquisition of an altered, proﬁbrotic
cellular phenotype. Consistently, the opposite effects were observed for CRT knockdown. Subse-
quently, we conﬁrmed that critical changes observed in vitro were also apparent in tubular cells
in vivo in the animal model of unilateral ureteric obstruction. In agreement with these results, we
demonstrate that substantial (50%) reduction in the expression of CRT reduced the development of
tubulointerstitial ﬁbrosis at a comparable level through regulation of inﬂammation, transcriptional
activation, transforming growth factor b1eassociated effects, and apoptosis. In summary, our
ﬁndings establish that CRT is critically involved in the molecular mechanisms that drive renal ﬁbrosis
progression and indicate that inhibition of CRT expression might be a therapeutic target for reduction
of ﬁbrosis and chronic kidney disease development. (Am J Pathol 2013,-: 1e14; http://dx.doi.org/
10.1016/j.ajpath.2013.07.014)102Supported by the European Union (European Social Fund-ESF) and
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Lifelong Learning of the National Strategic Reference Framework-Research
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123Chronic kidney disease (CKD), leading eventually to renal
failure and the need for replacement therapy, is frequently
observed in all adult populations, affecting >10% of indi-
viduals.1,2 Although CKD is the end result of several renal
and systemic diseases, its common anatomical feature is
progressive development of ﬁbrosis. This is a complex
process involving many cell types, of which the phenotype
becomes modiﬁed, and cascades of overlapping biochemical
pathways.3e6 Currently, several aspects of these events are
poorly understood.
Previously we have performed proteomic analysis of
renal parenchyma of the well-established rodent model of
unilateral ureteric obstruction (UUO).7,8 Our initial studies
indicated that calreticulin (CRT) is among the proteins that
are consistently up-regulated from the earliest stages of the
process of renal ﬁbrosis, even before the extracellular matrix
(ECM) begins to accumulate.9 Up-regulation was conﬁrmed
at the protein and mRNA levels and was localized exclu-
sively in tubular epithelial cells (TECs).9stigative Pathology.
.
A 5.2.0 DTD  AJPA1470_proof CRT is a multifunctional endoplasmic reticulum (ER)
protein that acts as a molecular chaperone and Ca2þ-binding
molecule. However, it has also been found in other cellular
compartments such as the cell surface and in the extracellular
environment. Altered expression or localization of CRT alters
cellular functions including the Ca2þ storage capacity of ER,
cell adhesiveness, proliferation and apoptosis, gene expression,
and immune system function.10,11 Furthermore, it is essential
for cardiac development and mouse embryogenesis.12 Recent
studies have implicated CRT in wound healing and chronic
kidney transplant rejection.11,13 However, our initial observa-
tion was the ﬁrst to involve CRT in the ﬁbrotic process.9124




























































































































247In the present study, using an in vitro approach, we
investigated alterations in the cellular phenotype when
CRT expression was increased in cultured renal TECs.
We demonstrated that these cells acquired a more mesen-
chymal character reminiscent of initial steps of epithelial-
mesenchymal transition (EMT), exhibited excessive and
selective ECM production, and showed increased ER stress
and apoptosis. Consistently, signiﬁcant reduction of CRT
expression by shRNA-mediated knockdown suppressed
both proﬁbrotic and proinﬂammtory markers. Subsequently,
we examined and conﬁrmed that some of the observed
changes in vitro were also apparent in tubular cells in vivo in
the animal model of UUO. In addition, we evaluated the
effect of drastic reduction in expression of CRT in hetero-
zygous transgenic mice14 on development of ﬁbrosis in the
UUO model and observed that reduction of CRT conferred




Human proximal TECs (HK-2) were purchased from ATCC
(Manassas, VA). The cells were grown 1:1 in Dulbecco’s
modiﬁed Eagle’s medium [4.5 g/L glucose and F-12 supple-
mented with 10% fetal bovine serum (FBS), 100 mg/mL
penicillin-streptomycin, and 2 mmol/L L-glutamine] and were
subcultured according to the manufacturer’s instructions.
CRT-overexpressing HK-2 cell lines were generated via
stable transfection of pcDNA3.1/hygro plasmid carrying
mouse CRT cDNA (kindly provided by Dr. Yoshito Ihara,
Wakayama Medical School, Japan). Control cells were
transfected with the empty vector. In brief, HK-2 cells were
transfected in six-well plates with pcDNA3.1-hygroemouse
CRT or empty vector using lipofectamine 2000 transfection
reagent (Invitrogen Corp., Carlsbad, CA). After 2 days, the
cells were transferred to 10-mm culture dishes and grown in
normal medium plus 200 mg/mL hygromycin B (Merck &
Co., Inc., Whitehouse Station, NJ), which was renewed
every 2 or 3 days. After 10 to 12 days, stable clones were
removed and individually expanded. The expression level of
CRT in each clone was examined via Western blotting. The
selected clones were then maintained in normal growth
medium supplemented with 100 mg/mL hygromycin.
CRT knockdown HK-2 cell lines were generated with
stable transfection of pSuper.retro.puro vector carrying an
shRNA sequence speciﬁc for human CRT. Control cells
were transfected with the empty vector. In brief, shRNA
sense and antisense sequences were annealed and cloned
into pSuper.retro.puro vector in BglII-XhoI restriction sites.
HK-2 cells were transfected in six-well plates with
pSuper.retro.puro-CRT shRNA or empty vector, as above.
Stable clones were selected in 2 mg/mL puromycin (Appli-
Chem GmbH, Darmstadt, Germany). The expression level
of CRT in each clone was examined via Western blotting.2
FLA 5.2.0 DTD  AJPA1470_proof The selected clones were then maintained in normal growth
medium supplemented with 1 mg/mL puromycin. The





For transforming growth factor beta1 (TGF-b1) treatment
of the CRT knockdown cells, the cells were incubated with
or without 5 ng/mL TGF-b1 (Sigma Q, St. Louis, MO) in
serum-deprived medium for 48 hours, after which they were
collected for Western blotting or quantitative RT-PCR (RT-
qPCR) analysis.
Animals
Eight- to 12-week-old male Wistar rats were supplied from
the colony of our Center for Experimental Surgery. For the
UUO model, rats underwent ligation of the right ureter, and
sham-operated rats were used as controls, as described
previously.9
CRT heterozygous (CRTþ/) C57BL/6 mice, expressing
only one functional CRT allele, and their wild-type (WT)
littermates were provided by Dr. Marek Michalak
(University of Alberta, Canada) and have been previously
described.14 For the UUO model, 12-week-old CRTþ/ and
WT male mice underwent ligation of the right ureter, and
the contralateral kidneys served as controls. All aspects of
animal experimentation were performed in adherence to the
NIH and the European Union Guide for the Care and Use
of Laboratory Animals and were approved by the Institu-
tional Review Board of the Biomedical Research Founda-
tion of the Academy of Athens.
Western Blot Analysis
Proteins from cell cultures and tissue samples were
extracted in radioimmunoprecipitation assay buffer [50
mmol/L Tris (pH 7.4), 1% NP-40, 0.25% deoxycholate
(DOC), 150 mmol/L NaCl, 1 mmol/L Na2EDTA, 1 mmol/L
phenylmethylsulfonyl ﬂuoride, and cocktail protease
inhibitors] and measured for protein concentration using the
Bradford method, and equal protein amounts were loaded
in an SDS-PAGE apparatus, followed by Western blotting.
The primary antibodies used were CRT (catalog No. 06-
661; Upstate Biotechnology, Inc., Lake Placid, NY), E-
cadherin (BD 610181; BD Biosciences, San Jose, CA),
vinculin (Sigma V9131; Sigma), vimentin (catalog No.
MS-129; Thermo Scientiﬁc, Inc., Waltham, MA), GRP78
(AP06149PU-N; Acris Antibodies GmbH, Herford,
Germany), ﬁbronectin (sc-8422; Santa Cruz Biotechnology,
Inc., Santa Cruz, CA), COL1A1 (sc-25974; Santa Cruz
Biotechnology), phospho-Smad3 (ab52903; Abcam, Cam-
bridge, England), Smad3 (catalog No. 3102; Cell Signaling
Technology, Inc., Danvers, MA), b-actin (catalog No.
A5316; Sigma), and b-tubulin (ab6046; Abcam).ajp.amjpathol.org - The American Journal of Pathology
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371For Col1A1 immunoblotting in conditioned medium,
cells were cultured for 24 hours in normal growth medium
and then in serum-deprived medium for 48 hours. Condi-
tioned medium was then collected with protease inhibitors,
centrifuged to pellet cells, and concentrated three times in
a Concentrator 5301 (Eppendorf AG, Hamburg, Germany).
Equal volumes from different samples were loaded in
a normal SDS-PAGE apparatus, followed by Western
blotting. For evaluation of Col1A1 levels separately in the
cellular and ECM compartments, DOC separation of the
fractions was performed according to the method of Van
Duyn Graham et al.15 In brief, cells were seeded in six-well
plates, cultured for 24 to 48 hours in normal growth
medium, and then in serum-deprived medium for another 48
hours. The cells and ECM were washed with PBS and
harvested by scraping in 4% DOC solution [4% DOC in 20
mmol/L Tris HCl (pH 8.8), with 1 protease inhibitors].
Lysates were homogenized with a 27½-gauge needle and
pelleted at 13,000 rpm for 30 minutes at 4C. The super-
natant was kept as the DOC-soluble cellular fraction, and
the pellet containing the DOC-insoluble ECM fraction was
washed with 4% DOC solution and resolubilized in 1%
SDS, 25 mmol/L Tris HCl (pH 8.0), plus protease inhibitors.
The total DOC insoluble fraction and one-tenth of the DOC-
soluble fraction were loaded in a normal SDS-PAGE
apparatus, followed by Western blotting. Each experiment
was performed in duplicate or triplicate and was repeated
three times.
RT-qPCR
Total RNA was prepared from cultured cells and mouse
kidney tissue using TRI reagent (Molecular Research
Center, Cincinnati, OH) according to manufacturer’s
instructions. For the cell preparations, cells were seeded in
six-well plates in normal growth medium and were cultured
for 48 to 72 hours until they were near conﬂuence. The
quality of the RNA was veriﬁed on agarose gels, and the
quantity was measured using a Spectronic photometer
(Thermo Fisher Scientiﬁc). Total RNA, 1 mg, was reverse
transcribed using ImProm-II reverse transcriptase (Promega
Corp., Madison, WI). We performed RT-qPCR using ABI
Prism 7000 software (Applied Biosystems, Inc., Foster City,
CA), with Platinum TaqDNA polymerase (Invitrogen),
three-step standard cycling conditions, and sequence-
speciﬁc primers. We performed a melting curve analysis
to verify that a single product was ampliﬁed. For quantita-
tive analysis, experimental genes were normalized to 18S
rRNA or GAPDH gene expression using the DDCT method.
The experiments were performed in triplicate and were
repeated three times.
Proliferation Assay
Cell proliferation was studied using a BrdU-incorporation
immunolabeling assay. Cells were seeded on coverslips andThe American Journal of Pathology - ajp.amjpathol.org
FLA 5.2.0 DTD  AJPA1470_proof cultured for 24 to 48 hours. After 2 hours of incubation with
BrdU solution, the cells were ﬁxed in 4% paraformaldehyde,
permeabilized with 2N HCl, blocked with 5% FBS, and
incubated with a primary anti-BrdU antibody (ab6326;
Abcam). A ﬂuorescent secondary antibody (anti-rat Alexa
Fluor; Invitrogen) was used for detection of the BrdU-
positive signal. The cells were counterstained with DAPI
for nuclei visualization and mounted on slides in Mowiol
4-88 reagent (Calbiochem, EMD Millipore, Billerica, MA).
Random non-overlapping images were obtained at 200
magniﬁcation with the use of a ﬂuorescent microscope (DM
RA2; Leica Microsystems GmbH, Wetzlar, Germany) fol-
lowed by manual counting of BrdU-positive signals in 500
cells per sample. Each experiment was performed in duplicate
or triplicate and was repeated three times. Data were
expressed as percentage of BrdU-DAPI ratio.
Apoptosis Assay
Apoptosis was assessed using a ﬂuorescein TUNEL kit (Roche
Applied Science, Penzberg, Upper Bavaria, Germany),
according to manufacturer’s instructions. To sensitize cells with
H2O2 before apoptosis assessment, cells were incubatedwith 50
mmol/L H2O2 in growth medium for 2 hours. In brief,
paraformaldehyde-ﬁxed cells on coverslips or rehydrated
formalin-ﬁxed, parafﬁn-embedded (FFPE) mouse kidney
sections were permeabilized with 0.1% Triton X-100 in 10
mmol/L sodium citrate (pH 6.0), followed by incubation with
TUNEL reaction mixture for 1 hour at 37C. Samples were
counterstainedwithDAPI andmounted inMowiol 4-88 reagent
(Calbiochem). Random non-overlapping images were obtained
at 200 magniﬁcation using a ﬂuorescent microscope (DM
RA2; Leica) followed by manual counting of TUNEL-positive
signals in 500 cells per sample for the cell experiments or in 8 to
10 high-power ﬁelds per sample for the tissue experiments.
Each experiment was performed in duplicate or triplicate and
was repeated two or three times. Cell data were expressed as
percentage of TUNEL-DAPI counts, and tissue data were
expressed as tubular TUNEL counts per high-power ﬁeld.
For double staining, FFPE rat kidney sections were
stained with TUNEL as described, followed by immuno-
ﬂuorescence labeling with anti-CRT antibody.
Cleaved-caspase 3 staining was also indicative of
apoptosis in cultured cells (see Immunoﬂuorescence).
Motility Assay
Cell motility was assessed using a wound-healing closure
assay. The cells were cultured in 48-well plates in duplicate
until they reached conﬂuence. Then the growth medium was
replaced with serum-deprived medium at 24 hours before
wound induction. Three hours before wound induction,
mitomycin C was added to the cells at a ﬁnal concentration
of 10 mg/mL in serum-deprived medium, to stop cell
proliferation. To create the wound, a plastic pipette tip was
gently drawn across the center of the well to produce a clean3
372




Figure 1 Calreticulin (CRT) overexpression and knockdown in tubular
epithelial cells (TECs). Western blot normalized to b-actin expression and
corresponding quantiﬁcation of CRT-overexpressing cells (A) and CRT
knockdown TECs (B). Control, cell line transfected with control vector;
overexpression 1 or overexpression 2, cell line with overexpression.
Quantiﬁcation corresponds to means  SD of three independent experi-




























































































































495wound approximately 1 mm wide. Images of the cells were
obtained at 50 magniﬁcation using an Axiovert 200
microscope (Carl Zeiss GmbH, Jena, Germany) at 0, 24, 48,
and 72 hours after wound induction. To quantify cell
migration, the wounded area was measured using ImageJ
(NIH, Bethesda, MD). The experiment was repeated three
times. Data were expressed as the percentage of the
remaining wounded area at each time point.
Immunoﬂuorescence
Cells were seeded on coverslips in 24-well plates in duplicate
and cultured for 24 to 48 hours. To induce oxidative stress
before cleaved caspase-3 staining, cells were incubated with 50
mmol/L H2O2 in growth medium for 2 hours. The coverslips
were removed from the wells, and the cells were ﬁxed in 4%
paraformaldehyde, blocked with a 5% FBS solution, incubated
with primary antibodies to collagen IV (C1926; Sigma) or
cleaved caspase-3 (catalog No. 9661; Cell Signaling Tech-
nology), developed using Alexa Fluor ﬂuorescent secondary
antibodies (Invitrogen), counterstained with DAPI, and moun-
ted in Mowiol 4-88 reagent (Calbiochem). Random non-
overlapping images were obtained at 200 magniﬁcation
using a ﬂuorescent microscope (Leica DM RA2). For quanti-
ﬁcation of cleavedcaspase-3 staining, 500cells per samplewere
manually counted. The experiments were repeated three times.
For dual immunolabeling, FFPE rat kidney sections were
rehydrated, treated for antigen retrieval with 10 mmol/L
sodium citrate (pH 6.0) at 100C for 10 minutes, blocked
with a 10% FBS solution, incubated with primary antibodies
to GRP78 (AP06149PU-N; Acris Antibodies)/CRT (catalog
No. 06-661; Upstate Biotechnology) or CRT alone after
TUNEL staining, developed using Alexa Fluor ﬂuorescent
secondary antibodies (Invitrogen), counterstained with
DAPI, and mounted in Mowiol 4-88 reagent (Calbiochem).
Double immunoﬂuorescence images were obtained using
a Leica inverted confocal microscope.
For a-SMA immunostaining, FFPE mouse kidney
sections were rehydrated, treated for antigen retrieval with
10 mmol/L sodium citrate (pH 6.0) at 80C for 20 minutes,
blocked with a 10% FBS solution, incubated with antie
a-SMA primary antibody (Abcam), developed using Alexa
Fluor ﬂuorescent secondary antibody (Invitrogen), coun-
terstained with DAPI, and mounted in Mowiol 4-88 reagent
(Calbiochem). Non-overlapping images of the entire cortex
were obtained using a Leica inverted confocal microscope at
400 magniﬁcation. The a-SMAepositive area (expressed
as percentage of total area excluding large vessels) was
quantiﬁed in all of the images using publicly available
image processing software (ImageJ Fiji; NIH).
Histology
FFPE kidney sections stained with Sirius Red were used
for histologic analysis. Slides were examined, and non-
overlapping images of the entire cortex were obtained using4
FLA 5.2.0 DTD  AJPA1470_proof a Leica DM LS2 microscope and a Leica DFC 500 camera
at 400 magniﬁcation. The tubulointerstitial area stained
(expressed as percentage of total area excluding glomeruli
and large vessels) was quantiﬁed in all of the images using
ImageJ Fiji.
Statistical Analysis
Results are presented as means  SD. To analyze the
difference between two data sets, the two-tailed Student’s
t-test was used, and for multiple group comparisons, anal-
ysis of variance with post hoc analysis. P < 0.05 was
considered signiﬁcant.Results
Altered CRT Expression in TECs Inﬂuences Their
Motility, Stress, Apoptosis, and Proliferation
To understand how CRT up-regulation in the tubular cells of
the kidney affects the progression of ﬁbrosis, we analyzed
the phenotype of both CRT-overexpressing and CRT
knockdown TECs. For overexpression, we used an estab-
lished proximal TEC line (HK-2) and created HK-2 cell
lines that stably overexpressed mouse CRT cDNA, using
one cell line with low and one with high CRT over-
expression, as well as one control line transfected with the
control vector (Figure 1A). Compensatory down-regulation
of the human CRT transcript was observed for the cell line
with the greater total CRT expression, possibly explaining
why higher overexpression folds were not achieved
(Supplemental Figure S1). For knockdown, we createdajp.amjpathol.org - The American Journal of Pathology
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Figure 2 Calreticulin (CRT) overexpression alters the structure,
motility, and proliferative capacity of tubular epithelial cells (TECs). A:
Representative images of control and CRT-overexpressing TECs in culture
show loss of epithelial adhesion and acquisition of a more elongated,
mesenchymal-like structure due to CRT overexpression. B: Wound-healing
assay in the presence of mitomycin C to inhibit proliferation shows
increased motility and wound closure of CRT-overexpressing cells up to 72
hours after wound induction. C: BrdU-incorporation assay shows decreased
proliferation of CRT overexpressors. Results are expressed as percentage of
BrdU-DAPI ratio for each cell line. The number of DAPI-positive cells
counted for each cell line is indicated above the respective graph bars. Data
represent means  SD of three independent experiments. *P < 0.05, **P <
0.01, and ***P < 0.001 versus control. Scale bars: 250 mm (A).
Figure 3 Calreticulin (CRT) overexpression in tubular epithelial cells
(TECs) induces endoplasmic reticulum (ER) stress and cellular apoptosis
mechanisms. A: Representative blot shows increased GRP78 expression, an
endoplasmic reticulum stress sensor, in CRT-overexpressing cells. Quanti-
ﬁcation corresponds to means  SD of three independent experiments.
TUNEL-positive nucleieDAPI ratio (B) and cleaved caspase-3eDAPI ratio
(C) in control and CRT-overexpressing cells under normal growth conditions
or after treatment with 50 mmol/L H2O2 for 2 hours. The number of DAPI-
positive cells counted for each cell line is indicated above the respective
graph bars. Data represent means  SD of three independent experiments.
D: Representative blot shows increased GRP78 expression in CRT knockdown
cells. Quantiﬁcation corresponds to means  SD of three independent
experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control.



























































































































619HK-2 cell lines that stably expressed an shRNA molecule
speciﬁcally targeting human CRT and used two cell lines
with signiﬁcant knockdown of CRT expression and one
control line transfected with the empty vector (Figure 1B).
It was observed that, compared with control cells, CRT-
overexpressingTECsweremore elongated andmesenchymal-
like and adhered more loosely to each other (Figure 2A).
Next we examined motility using a wound-healing closure
assay. Compared with control cells, CRT-overexpressing
cell lines displayed signiﬁcantly increased motility up to
72 hours after wound induction, proportional to the level of
CRT expression (Figure 2B). This phenomenon was not
due to an increase in proliferation rate becausemitomycin C
was added to the assay to differentiate proliferation from
migration. Moreover, in BrdU-incorporation assays, the
overexpressing cell lines showed reduced proliferation
(Figure 2C). The smaller total number of DAPI nuclei
counted in CRT-overexpressing cells compared with
control cells (Figure 2C) suggests that the overexpressing
cells proliferate more slowly.
Next we studied the intracellular stress state by examining
the expression levels of GRP78, a major ER stress sensor.16
CRT-overexpressing cells displayed signiﬁcantly increased
levels of GRP78, showing that CRT up-regulation induces
ER stress response mechanisms (Figure 3A). Inasmuch asThe American Journal of Pathology - ajp.amjpathol.org
FLA 5.2.0 DTD  AJPA1470_proof ER stress progression can lead to apoptosis and cell death,17
we assessed the levels of cellular apoptosis using the
TUNEL assay, which detects DNA fragmentation. Com-
pared with control cells, CRT-overexpressing cells showed
a twofold increase in apoptosis under normal culture
conditions. After treatment with H2O2, apoptosis of the
overexpressing cells was dramatically increased, in partic-
ular for the clone with greater CRT expression (Figure 3B).
The total number of DAPI-positive cells counted for the
TUNEL assay was reduced in the overexpressing cells
compared with control cells, in particular after treatment
with H2O2 (Figure 3B), which suggests that CRT over-
expressors died massively in response to H2O2. In addition,
cleaved caspase-3 expression, which detects activation of
the execution phase of apoptosis, assessed via immuno-
staining, was increased in the overexpressing cells in the
absence or presence of H2O2 in the growth medium
(Figure 3C). The difference between cleaved caspase-
3epositive and TUNEL-positive cells after H2O2 treatment
may indicate that there are caspase-3eindependent mecha-
nisms that induce DNA fragmentation in the CRT5
620
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Figure 4 Altered expression of epithelial and mesenchymal markers
caused by calreticulin (CRT) overexpression or knockdown in tubular epithelial
cells (TECs). A: Representative blots show substantially reduced E-cadherin
and increased vimentin and vinculin expression in CRT-overexpressing cells.
The lanes were run on the same gel but were noncontinguous. Quantiﬁcation
corresponds to means  SD of three independent experiments. B: Relative
mRNA amount (RT-qPCR) of several EMT markers (E-cadherin, Vimentin, Acta2,
Snai1, Snai2) in control and CRT-overexpressing cells. C: Representative blot
of E-cadherin expression in TECs underexpressing CRT with or without TGF-b1
treatment. E-cadherin is remarkably increased in knockdown cells, and its
suppression by TGF-b1 is compromised. D: Relative mRNA amount of TGF-b1
response genes in CRT knockdown cells. CRT suppression impairs TGF-b1
signaling in TECs. Data represent means  SD of three independent experi-
ments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control; yP < 0.05,




























































































































743overexpressors under conditions of oxidative stress. More-
over, the higher level of unstimulated apoptosis due to CRT
overexpression observed in both TUNEL and caspase-3
assays may be attributed to the increased expression of
activated caspase-3 in the overexpressing cells or may be
induced through ER stress mechanisms triggered by CRT
overexpression.
In the CRT knockdown cells, a signiﬁcant increase in
GRP78 levels was also observed (Figure 3D), probably to
compensate for the considerable CRT suppression. However,
the function of GRP78 and the purpose of ER stress induction
likely differ between CRT knockdown and overexpressing
cells. Consistently, CRT knockdown cells did not display any
important change in apoptosis or viability rates in TUNEL,
caspase-3, or BrdU assays, features that could be inﬂuenced
by ER stress (data not shown). It seems that reduction of CRT6
FLA 5.2.0 DTD  AJPA1470_proof levels is not so crucial for proliferation and apoptosis of TECs
as is its overexpression. Moreover, the unaltered activated
caspase-3 expression may account for the failure to observe
protection from apoptosis of the CRT knockdown cells (data
not shown).
CRT Overexpression or Knockdown in TECs Alters
Expression of Epithelial and Mesenchymal Markers
Because progression of ﬁbrosis has been associated with
changes in the epithelial cell phenotype,5,6 we examined the
expression levels of epithelial and mesenchymal protein
markers in both CRT-overexpressing and knockdown TECs.
The epithelial junctional protein E-cadherin was substantially
decreased in the overexpressing cells. In parallel, mesen-
chymal proteins such as vinculin and vimentin were
increased (Figure 4A). These results showed that CRT up-
regulation causes a decline of the epithelial cell phenotype
in favor of a more mesenchymal character.
To conﬁrm previous ﬁndings, we further characterized
several markers at the gene expression level. E-cadherin and
vimentin expression followed the same pattern as did protein
expression (Figure 4B). Snai1 (snail) and Snai2 (slug), two
transcriptional repressors of E-cadherin and strong inducers
of EMT,18e20 were signiﬁcantly up-regulated in CRT-
overexpressing cells. However, expression levels of Acta2
(the gene name for a-SMA), the most commonly used marker
for myoﬁbroblasts, were decreased in the CRT over-
expressors, indicating that despite their phenotypic change,
CRT-overexpressing TECs are not promoted to reach EMT.
CRT knockdown led to an important increase in
E-cadherin expression at both the protein (Figure 4C) and
mRNA (Figure 4D) levels, showing the opposite phenotype
as the overexpressing TECs. Other EMT markers such as
Snai1 and Acta2 were not changed by CRT suppression
(Figure 4D). However, induction of both Snai1 and Acta2
after TGF-b1 treatment was completely abolished in the CRT
knockdown TECs. Furthermore, suppression of E-cadherin
induced by TGF-b1 was partially attenuated (Figure 4D).
These results show that down-regulation of CRT expression
inhibits several TGF-b1edriven responses of epithelial cells
in culture, supporting a proﬁbrotic role of CRT.
Altered CRT Expression Levels Change the Secretory
Proﬁle of TECs
As ﬁbrosis development is highly based on ECM accumu-
lation, we tested whether CRT up-regulation or knockdown
in TECs affects the production of ECM components. Fibro-
nectin expression was signiﬁcantly increased in the CRT-
overexpressing cells, at both the protein and mRNA levels
(Figure 5, A and D). In addition, collagen IV, an epithelial
collagen type and basic component of the tubular basement
membrane, was notably up-regulated in the CRT over-
expressors at both the protein and mRNA expression levels
(Figure 5, B and D). However, collagen I, which is known toajp.amjpathol.org - The American Journal of Pathology
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832be produced by ﬁbroblasts, was not increased in TECs
overexpressing CRT, neither at the protein (conditioned
medium, cell, and ECM fractions) nor at the transcript level
(Figure 5, C and D). That Col1A1 was completely absent
from the ECM fraction of TECs is in total agreement with the
epithelial character of the well-differentiated cell line used
and the composition of the renal tubular basement
membrane. In contrast, CRT knockdown led to a dramatic
decrease in Col1a1 expression, without signiﬁcantly
affecting expression of Fn1 or Col4a1 transcripts
(Figure 5E). These results indicate that CRT overexpression
in TECs promotes selective production of ECM components
without inducing complete mesenchymal transformation of
TECs; however, its suppression is able to attenuate the
expression of primary mesenchymal markers such asCol1a1.
CRT-Overexpressing Tubular Cells in Vivo Display
Increased Cellular Stress
Cellular stress originating from ER is increasingly recognized
as a major mechanism contributing to the progression of renal
ﬁbrosis.21 Because we found that CRT up-regulation in
cultured TECs induces ER stress, we sought to conﬁrm
whether tubular cells overexpressing CRT in vivo in the UUOThe American Journal of Pathology - ajp.amjpathol.org
FLA 5.2.0 DTD  AJPA1470_proof model display similar characteristics. Thus, we performed
double immunoﬂuorescence staining of kidney sections from
control (sham-operated) mice and at 2 or 8 days in animals
who underwent ureter ligation (L2 and L8, respectively).
GRP78, an indicator of ER stress, and CRT were expressed at
relatively low levels in control animals (Figure 6). However,
the level of both proteins gradually increased at 2 and 8 days
after ureteric obstruction and displayed broad co-localization
in the tubular cells of the ﬁbrotic kidney.
CRT Heterozygous Mice Demonstrate Improved Kidney
Appearance and Reduced Collagen Accumulation in the
UUO Model
Because our observations indicated that CRT up-regulation
in TECs induces a proﬁbrotic cell phenotype, we used an
animal model with reduced CRT expression, mice hetero-
zygous for CRT,14 to directly investigate its role in ﬁbrosis
progression in the UUO model.
Initially, we conﬁrmed that heterozygous mice produce
approximately half the amount of CRT as their WT litter-
mates do (Figure 7A). To analyze late stages of the disease
progression, mice were sacriﬁced at days 8 and 17 after
UUO.Figure 5 Calreticulin (CRT) overexpression in
tubular epithelial cells (TECs) induces selective
productionof extracellularmatrix (ECM) components.
A: Representative blot shows signiﬁcantly increased
ﬁbronectin expression in CRT-overexpressing cells.
Quantiﬁcation corresponds to means  SD of three
independent experiments. B: Representative images
of collagen IV immunostaining on control and CRT-
overexpressing cells show marked up-regulation in
overexpressors. C: Representative blots show COL1A1
expression in conditioned medium, ECM, and cell
fractions of control, and CRT-overexpressing cells.
Ponceau S staining was used as loading control.
COL1A1, a ﬁbroblast-speciﬁc collagen, is not in-
creased by CRT up-regulation in TECs. D: Relative
mRNA amount (RT-qPCR) of Col1a1, Col4a1, and
Fibronectin. Transcript levels follow the same pattern
as protein expression. E: Relative mRNA amount
(RT-qPCR) of ECM molecules in CRT knockdown TECs
shows signiﬁcant suppression of Col1a1 and no
change in Col4a1and Fn1. Data representmeans SD
of three independent experiments. *P< 0.05, **P<

























































Figure 6 Increased cellular stress characterizes calreticulin (CRT)-
overexpressing tubular cells in vivo. Representative double immunostaining
images of GRP78 (green) and CRT (red) in control (sham-operated) mice
and at 2 or 8 days after ureteric ligation in study animals (L2 and L8,
respectively). Both GRP78 and CRT are expressed at low levels in control
animals but are gradually increased and highly co-localized in the tubular
cells of the ﬁbrotic kidney after 2 and 8 days of UUO (yellow), indicating





























































































































991At 17 days after UUO, there was a notable anatomical
difference between the ligated kidneys of WT and hetero-
zygous mice. The ligated kidneys of WT mice displayed
markedly severe dilatation and color change compared with
the respective kidneys of CRT heterozygous mice
(Figure 7B). The same phenomenon was observed to
a lesser extent at 8 days after UUO (data not shown). This
improved appearance of the obstructed kidneys in hetero-
zygous mice was the ﬁrst indication to positively correlate
CRT abundance with ﬁbrosis progression.
To further investigate whether CRT reduction affects ECM
deposition during tissue ﬁbrosis, we performed Sirius Red
staining of kidney sections from WT and heterozygous mice.
Quantiﬁcation of the extent of Sirius Red staining showed that
there was substantially reduced collagen accumulation in the
kidneys of heterozygous mice, both at 8 and 17 days after
UUO (Figure 7C). Collagen accumulation was decreased by
35% at 8 days and by 50% at 17 days, indicating that reduction
in CRT expression protects from ECM deposition up to very
late stages of ﬁbrosis progression.
CRT Heterozygous Mice Demonstrate Altered
Expression of Key Molecules That Regulate Progression
of Fibrosis
We then examined the expression levels of several major
proﬁbrotic and proinﬂammatory molecules along with the
expression levels of CRT in the mouse UUO model.8
FLA 5.2.0 DTD  AJPA1470_proof RT-qPCR analysis showed that CRT was up-regulated with
progression of ﬁbrosis but was signiﬁcantly reduced in
heterozygous mice compared with WT mice. However,
greater reduction was observed at 17 days after obstruction,
indicating that CRT expression in heterozygous mice was
not proportionally reduced at all time points (Figure 8A). In
accordance with CRT expression levels, the proﬁbrotic
genes examined, including the ECM components Col1a1,
Col3a1, Col4a1, and Fn1 (ﬁbronectin), the proﬁbrotic
growth factor TGF-b1, and the transcription factors Snai1
and Snai2, were notably attenuated in heterozygous mice,
but to a lesser extent at 8 days than at 17 days after UUO
(Figure 8B). Moreover, examination of the expression levels
of E-cadherin as a marker of epithelial integrity revealed an
important reduction in WT mice at 17 days after obstruction,
whereas its expression was not altered in heterozygous mice
(Figure 8C). Next, we determined the area of a-SMAe
positive myoﬁbroblasts and the expression levels of the
proinﬂammatory mediators TNF-a and MCP1. At 17 days
after obstruction, both a-SMA and proinﬂammatory gene
expression were signiﬁcantly attenuated in heterozygous
mice, comparable to the level of CRT reduction (Figure 8, D
and E). In summary, these results indicate that CRT may
positively regulate activation of proﬁbrotic and proin-
ﬂammatory pathways and that reduction of its levels is able
to efﬁciently attenuate the progression of ﬁbrosis.
Renal Tubular Cells in CRT Heterozygous Mice Are
Protected from Apoptosis during Fibrosis Progression
Because apoptosis has a major role in tubular cell loss
during ﬁbrosis development,5,22 we investigated whether
reduction of CRT affects tubular apoptosis in the UUO
model. TUNEL staining of kidney sections showed that,
compared with WT mice, CRT heterozygous mice demon-
strate markedly less tubular apoptosis at both 8 and 17 days
after obstruction (Figure 9). This decrease in tubular
apoptosis is comparable to the expression level of CRT after
UUO (Figure 8A).
CRT Levels Affect Expression of Molecules Being
Upstream or Downstream TGF-b1 Signaling
Inasmuch as CRT partial deﬁciency in heterozygous mice
repressed expression of TGF-b1, a key mediator of proﬁ-
brotic events, we investigated whether CRT may regulate
TGF-b1 production and/or activation.
Thrombospondin 1 (TSP1) is a complex matricellular
protein that regulates latent TGF-b1 activation and has
a role during tissue repair and ﬁbrosis.23,24 We showed that
TSP1 was up-regulated along with development of ﬁbrosis,
yet its expression was signiﬁcantly reduced in CRT
heterozygous mice compared with WT littermates at both
time points examined (Figure 10A). Next, we examined
how CRT levels may affect TSP1 expression in the CRT-
overexpressing or knockdown TECs. CRT up-regulationajp.amjpathol.org - The American Journal of Pathology
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1064induces a proportional increase in TSP1 expression levels
(Figure 10B). Experiments performed on CRT-knockdown
TECs showed that CRT deﬁciency reduces TSP1 expres-
sion signiﬁcantly (Figure 10C). These results collectively
indicate that CRT levels directly affect TSP1 expression and
thus may regulate TSP1-mediated TGF-b1 activation.
Furthermore, we investigated the effect of CRT levels on
expression of proinﬂammatory mediators because inﬂam-






FLA 5.2.0 DTD  AJPA1470_proof ﬁbrosis.25 All three cytokines examined (MCP1, TNF-a,
and IL-8) were remarkably increased in the CRT-
overexpressing TECs (Figure 10D). In contrast, MCP1
and TNF-a were signiﬁcantly reduced in CRT knockdown
TECs (Figure 10C). This is consistent with repression of
MCP1 and TNF-a levels in CRT heterozygous mice during
ﬁbrosis progression (Figure 8E) and associates CRT with
regulation of inﬂammation and consequently TGF-b1
production.
In agreement with these ﬁndings, we showed that phos-
phorylated Smad3, a central mediator of TGF-b1 signaling,
is substantially attenuated in CRT heterozygous mice at
both time points of ﬁbrosis, clearly indicating lower acti-





























Renal ﬁbrosis is the common anatomical denominator
underlying the progression of CKD of various causes.3 Only
a detailed understanding of the mechanisms and macro-
molecules involved in ﬁbrosis progression will enable
development of targeted therapeutic interventions. In this
report, we demonstrated participation of CRT during
development of renal ﬁbrosis in vitro and in vivo. Our
studies in vitro with renal TECs showed that CRT up-
regulation was a causative factor for acquisition of an
altered, primarily proﬁbrotic cellular phenotype. Next, we
conﬁrmed that critical changes observed in vitro (cellular
stress and apoptosis) were also appearing in tubular cells
in vivo in the animal model of UUO. On the basis of these
observations, we reasoned that reduction of CRT may exert
a protective effect toward ﬁbrosis. Indeed, we demonstrated
that substantial reduction in expression of CRT in hetero-
zygous transgenic mice impressively attenuated the pro-
gression of tubulointerstitial ﬁbrosis.
How does CRT up-regulation in tubular cells affect
progression of renal ﬁbrosis? Overexpression of CRT in
cultured renal TECs caused the decrease of differentiated
epithelial cell markers (eg, E-cadherin) and acquisition ofFigure 7 Decreased calreticulin (CRT) expression in heterozygous mice
ameliorates unilateral ureteric obstruction (UUO)-induced tubulointerstitial
ﬁbrosis. A: Representative blot of CRT expression in heterozygous mice
(þ/) and their WT littermates shows that the heterozygous mice produce
approximately half the amount of CRT relative to their WT littermates.
Quantiﬁcation corresponds to means  SD of three independent experi-
ments. B: Representative images of the ligated and contralateral kidneys
from WT and CRTþ/ mice at 17 days after UUO shows that CRTþ/ mice
demonstrate less dilatation and better color preservation of the ligated
kidneys compared with WT mice, indicating slower progression of ﬁbrosis.
C: Representative images of Sirius Redestained kidney sections from WT
and CRTþ/ mice at 8 and 17 days after UUO. Quantiﬁcation of the staining
showed substantially reduced collagen deposition in the kidneys of
heterozygous mice at both time points. n Z 3 per group. The tubu-
lointerstitial area stained was quantiﬁed in non-overlapping images of the
entire cortex. **P < 0.01 versus WT; yP < 0.05 versus L8WT; zzP < 0.01



































Figure 8 Decreased calreticulin (CRT) levels in heterozygous mice change the ﬁbrotic proﬁle in unilateral ureteric obstruction (UUO)-induced tubu-
lointerstitial ﬁbrosis. A: Relative mRNA amount (RT-qPCR) of the CRT gene in kidney homogenates of control kidneys at 8 and 17 days after UUO in WT and
CRTþ/ mice shows that CRT is signiﬁcantly reduced in CRTþ/ compared with WT mice, with variable degree of reduction in control kidneys and kidneys at 8
and 17 days after UUO. B: Relative mRNA amount of key proﬁbrotic genes (Col1a1, Col3a1, Col4a1, Fn1, TGFb1, Snai1, and Snai2) in WT and CRTþ mice at 8 or
17 days after UUO shows a small repression at 8 days and notably increased repression at 17 days in heterozygous mice, consistent with the expression pattern
of CRT at the corresponding UUO time points. C: Representative blot of E-cadherin expression in WT and CRTþ/ mice at 8 or 17 days after UUO shows that
E-cadherin is substantially reduced at 17 days in WT but not in CRTþ/ mice, implicating better preservation of the epithelial structure in heterozygous
mice. D: Representative images of a-SMAestained kidney sections from WT and CRTþ/ mice at 17 days after UUO and quantiﬁcation of the staining in
non-overlapping images of the entire cortex shows signiﬁcantly reduced a-SMAepositive area in heterozygous mice. E: Relative mRNA amount of the
proinﬂammatory genes TNF-a and MCP1 in WT and CRTþ/ mice at 8 or 17 days after UUO shows that the proinﬂammatory mediators are repressed in
heterozygous mice after UUO to a degree consistent with the level of CRT expression (E). nZ 3 per group. *P < 0.05, **P < 0.01 versus control WT, L8WT, or









































































































1220a more mesenchymal phenotype, most likely through up-
regulation of the key EMT regulators Snai1 and Snai2
(Figure 4).18e20 That the low CRT overexpression caused
a greater decrease in E-cadherin expression is in total
agreement with the greater increase in Snai1 levels and
stronger activation of the b-catenin pathway in theFigure 9 Decreased calreticulin (CRT) levels in heterozygous mice protect
from tubular cell loss in unilateral ureteric obstruction (UUO)-induced tubular
interstitial ﬁbrosis. Number of tubular TUNEL-positive nuclei per high-power
ﬁeld in WT and CRTþ/ mice at 8 or 17 days after UUO. Tubular apoptosis is
notably decreased in heterozygous mice at both time points. nZ 3 per group.
Staining was quantiﬁed in 10 images at200 magniﬁcation per animal. *P<





















FLA 5.2.0 DTD  AJPA1470_proof overexpression 1 clone (data not shown). These results may
indicate that slight changes in CRT expression may be able
to disproportionally affect certain pathways at the cell
culture level and that ﬁne tuning of CRT levels intracellu-
larly may be important for cellular functions. However, in
the case of a complex tissue in which other factors and cell
types are also involved, these effects may be counter-
balanced. In agreement with these ﬁndings, a previous study
of Madin-Darby canine kidney cells evaluated the role of
CRT in induction of EMT.26 EMT previously has been
proposed to have a pivotal contribution to development of
renal ﬁbrosis.20,27 However, recent studies have challenged
this notion and have rendered the role of EMT highly
controversial.28,29 Interestingly, our results showed that
CRT overexpression in TECs did not induce expression of
either Acta2 (the gene coding for a-SMA), the most
commonly used marker for activated ﬁbroblasts and myo-
ﬁbroblasts, or Col1a1, the major collagen type produced by
ﬁbroblasts. Previous studies of ﬁbroblast cell lines have
proportionally correlated CRT abundance with collagen I
expression and deposition into the ECM.15 These results,
combined with our ﬁndings, indicate that CRT may regulate
certain cellular functions in a cell typeespeciﬁc manner. For
example, CRT up-regulation in TECs enhanced productionajp.amjpathol.org - The American Journal of Pathology
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Figure 10 Calreticulin (CRT) levels affect molecules being upstream or downstream transforming growth factor b1 (TGF-b1) signaling. A: Relative mRNA
amount of TSP1 in kidney homogenates of WT and CRTþ/ mice after 8 or 17 days of UUO shows that the TSP1 levels increase with progression of ﬁbrosis but
are signiﬁcantly repressed in mice lacking one CRT allele at both time points examined. nZ 3 per group. B: Relative mRNA amount of TSP1 in tubular epithelial
cells (TECs) overexpressing CRT shows up-regulation of TSP1. C: Relative mRNA amount of inﬂammatory molecules in CRT knockdown TECs shows signiﬁcant
suppression of TSP1, MCP1, and TNF-a. D: Relative mRNA increase in inﬂammatory cytokines MCP1, TNF-a, and IL-8 in TECs overexpressing CRT links CRT up-
regulation with mediation of a proinﬂammatory state triggered by renal TECs. E: Relative mRNA amounts were determined via RT-qPCR. Representative blot
shows reduction in pSmad3 expression in WT and CRTþ/ mice at 8 or 17 days after UUO, indicating an important attenuation of TGF-b1 signaling. Data
represent means  SD of three independent experiments. *P < 0.05, **P < 0.01 versus L8WT (A and E); yP < 0.05, yyP < 0.01 versus L17WT (A and E); zzP <
0.01, zzzP < 0.001 versus control (D).



























































































































1363of other ECM components including ﬁbronectin and
collagen IV, which are not ﬁbroblast speciﬁc. These data
suggest that CRT up-regulation initiates epithelial plasticity,
which may facilitate tubular cells to adjust to their ﬁbrotic
environment; however, it is in itself insufﬁcient for full
myoﬁbroblastic differentiation of epithelial cells, which can
be promoted in vitro by other factors such as TGF-b1. That
CRT repression in TECs suppressed both TGF-b1 responses
and Col1a1 expression shows that CRT promotes ﬁbrotic
pathways and that its reduction is able to attenuate expres-
sion of several ﬁbrotic markers. In agreement with these
ﬁndings, it was shown that knockdown of CRT in ﬁbroblast
cell lines attenuates TGF-b1einduced ECM production.30
In accordance with this alteration of cell phenotype was
acquisition of a more elongated architecture and increased
motility of the CRT-overexpressing TECs. Previous studies
of several cell lines have yielded contradictory results
insofar as the role of CRT in wound healing and modulation
of cell adhesiveness.31e35 For example, CRT over-
expression in ﬁbroblasts enhanced cell attachment efﬁcacy
on ﬁbronectin-coated matrices and reduced cell motility.31
In contrast, in vitro treatment with exogenous CRT
increased proliferation and migration of both epithelial cells
and ﬁbroblasts.35 The decreased proliferation rate of CRT-
overexpressing TECs in the present study can be attrib-
uted to the fact that endogenous ER resident CRT may exertThe American Journal of Pathology - ajp.amjpathol.org
FLA 5.2.0 DTD  AJPA1470_proof different functions from exogenously added CRT. Further-
more, it is possible that the inﬂuence of CRT on cell motility
differs between epithelial cells and ﬁbroblasts. Induction
of Tsp1 in CRT-overexpressing TECs, which promotes
focal adhesion disassembly and cell migration,23,33 may
have a role in the increased motility observed in CRT
overexpressors.
ER stress and apoptosis are increasingly appreciated as
major contributors to progression of renal ﬁbrosis.21,22 CRT,
apart from its other cellular functions, serves as an ER stress
response protein, being up-regulated by various stress
stimuli.36,37 Moreover, separate studies of a variety of cell
lines have attributed opposing roles to CRT in regulation of
apoptosis.38e44 For example, certain studies have propor-
tionally correlated CRT abundance with increased cell
sensitivity to apoptosis,38e41 whereas others have positively
associated CRT expression with protection from apoptosis
induced by diverse stimuli such as nitric oxide, hypoxia, or
intracellular Ca2þ overload.42e44 It is possible that the effect
of CRT on viability and apoptosis differs according to the
cell line used, the level of CRT expression, or the severity
and duration of the apoptotic stimulus. In the present study,
CRT overexpression in TECs aggravated the ER stress state
and rendered the cells prone to apoptotic death. In addition
to the data presented for GRP78, our preliminary studies
indicated that phosphorylation of the eukaryotic initiation11
1364




























































































































1487factor 2a (peIF2a), a crucial step in the stress-induced
signaling pathways,16,17 is increased in CRT-
overexpressing TECs (data not shown). CRT knockdown
in TECs also induced prominent up-regulation of GRP78
expression. This is consistent with the increased expression
of ER stress proteins, including GRP78 observed in CRT-
null mouse embryonic ﬁbroblasts.45 These data suggest
that CRT deﬁciency triggers an ER stress response to
compensate for accumulation of unfolded proteins and to
facilitate the protein quality control chaperoned in the ER.
In contrast, ER stress proteins also regulate ﬁbrotic
processes.46 Our results suggest that CRT overexpression in
TECs induced an ER stress response, in particular accom-
panied by ﬁbrotic changes and apoptosis, alterations that
were not observed in CRT knockdown TECs despite
increased expression of GRP78. Consistently, we conﬁrmed
the existence of broad ER stress in the CRT-overexpressing
tubular cells in vivo in the UUO model, in which a high
degree of co-distribution was noted. These observations
support the idea that CRT may contribute to renal ﬁbrosis
through ER stress and apoptosis induction.
Because CRT up-regulation in TECs causes phenotypic
alterations that may be considered crucial steps during the
progression of ﬁbrosis, can reduction of its expression have
protective effects on ﬁbrosis development? In that deletion
of the CRT gene causes embryonic lethality,14 the use of
heterozygous transgenic mice, with an approximately 50%
reduction in CRT expression, was an ideal tool for directly
investigating the role of CRT in ﬁbrosis. Although CRT was
up-regulated in the UUO model, as expected, its expression
in heterozygous mice was not proportionally reduced,
showing a greater decrease at 17 days of obstruction. It is
possible that the need for increased CRT expression led to
greater up-regulation of the single CRT allele in heterozy-
gous mice in the early stages of ﬁbrosis, which could not be
sustained to the later stages of the disease. Apparently, the
reduced expression of CRT in heterozygous mice is not
restricted to tubules, in which CRT is speciﬁcally up-
regulated in the UUO model of ﬁbrosis.9 The possibility
that decreased CRT expression in other cell types, including
interstitial ﬁbroblasts and immune cells, also affects the
progression of ﬁbrosis cannot be excluded. However, the
speciﬁc function of CRT in these cell types has been
extensively examined in other studies and is under
discussion.
In accordance with our hypothesis, CRT deﬁciency
notably improved the gross appearance of the ligated
kidneys, seen macroscopically with less dilatation and better
color preservation as compared with WT kidneys. This
delay of the ﬁbrotic process was further established and
quantitated via Sirius Red staining, which veriﬁed that the
kidneys of heterozygous mice had substantially reduced
ECM accumulation at both time intervals (ie, starting at day
8) and that this reduction was even more dramatic at 17 days
after UUO. The observation of a 35% reduction in Sirius
Red staining at 8 days after UUO accompanied by a smaller12
FLA 5.2.0 DTD  AJPA1470_proof 20% decrease in CRT transcript can be attributed to the fact
that CRT expression level corresponds to the speciﬁc time
point examined, whereas the area of Sirius Red staining
represents the total amount of ECM accumulated from onset
of the disease. Accordingly, the area of a-SMAepositive
myoﬁbroblasts and the expression levels of all ECM
molecules examined were attenuated in heterozygous mice,
most signiﬁcantly at 17 days after UUO, in accordance with
the greater reduction in CRT levels. In addition to the
decrease in ECM accumulation, CRT heterozygous mice
exhibited better preservation of the tubular structure, evi-
denced by the maintenance of E-cadherin expression and
attenuation of tubular apoptosis. Consistently, the tran-
scriptional regulators of EMT and ﬁbrosis, Snai1 and Snai2,
were repressed in heterozygous mice. These results are
conﬁrmed by our ﬁndings in cultured TECs and suggest that
CRT affects proﬁbrotic pathways, at least in part, by
inducing major transcriptional regulators of ﬁbrosis such as
Snai1 and Snai2.
A central mediator in these pathways is the proﬁbrotic
cytokine TGF-b1, the expression of which was attenuated in
CRT heterozygous mice. TGF-b1 mediates several key
pathologic events during CKD progression, including
ﬁbroblast activation, tubular and ﬁbroblast ECM produc-
tion, epithelial cell death, and inﬂammatory processes, and
the disruption of its signaling impeded development of
chronic renal damage.47,48 The major source of TGF-b1
during ﬁbrosis is the inﬁltrating inﬂammatory cells.25
Apparently, inﬂammation was attenuated in heterozygous
mice, as demonstrated by the decrease in inﬂammatory
mediators (MCP1 and TNF-a) and the smaller perivascular
inﬁltrates observed (data not shown). In TECs over-
expressing CRT, several inﬂammatory cytokines were
induced (MCP1, TNF-a, and IL-8), which suggests that
epithelial up-regulation of CRT during ﬁbrosis may be
involved in establishment of the inﬂammatory state that
characterizes the ﬁbrotic kidney, thereby increasing TGF-b1
production. Consistently, a number of immunologic func-
tions have already been ascribed to CRT. Cell surface
expression of CRT promotes the phagocytic uptake of dying
cells, assists in maturation of immune cells, and enhances
lymphocyte inﬁltration of tumors.49e52 That the cell surface
form of CRT promotes clearance of apoptotic cells does not
contradict the reduced tubular apoptosis observed in
heterozygous mice because it is possible that the decrease in
ER resident CRT attenuates tubular apoptosis. In addition,
CRT possibly may regulate TGF-b1 activation by directly
affecting expression of TSP1, an endogenous TGF-b1
activator, as shown by the prominent up-regulation of TSP1
in TECs overexpressing CRT and the impressive suppres-
sion of TSP1 in knockdown TECs. This result may seem
contradictory to the increased levels of TSP1 transcript
observed in CRT-null mouse embryonic ﬁbroblasts15;
however, this may be another example of cell typeespeciﬁc
phenomenon, highlighting the difference between the
responses of epithelial cells and ﬁbroblasts. Moreover, theajp.amjpathol.org - The American Journal of Pathology
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1565cell surface form of CRT binds to TSP1 and stimulates
events associated with wound healing including cell
migration, anoikis resistance, and matrix deposition, which
may also represent a mechanism through which CRT affects
ﬁbrosis.23,33,52 TSP1 expression was repressed in CRT
heterozygous mice both at earlier and later intervals,
implying that TGF-b1 activation was alleviated. Reduced
TGF-b1 activation was evidenced by the signiﬁcant
decrease in phosphorylated Smad3 levels at both time points
in heterozygous mice. Therefore, we suggest that CRT
deﬁciency attenuates progression of ﬁbrosis by suppressing
both TGF-b1 expression and activation and by hampering

























Results of the present study demonstrate that overexpression
of CRT in TECs is a critical regulator of several aspects of
tubulointerstitial ﬁbrosis development. Reduction of CRT
expression in transgenic heterozygous mice efﬁciently
ameliorates progression of ﬁbrosis by affecting inﬂamma-
tory processes, TGF-b1 production and/or activation, tran-
scriptional regulation of ﬁbrotic molecules, and apoptosis.
The ability of CRT to affect so many aspects of ﬁbrosis
indicates that decreasing CRT levels may represent a novel
targeted and effective treatment against ﬁbrosis and CKD.
The mechanisms of ﬁbrosis development in various organs
may have pathways shared in common or differing in
a tissue-speciﬁc manner. For example, in an animal model
of bleomycin-induced lung ﬁbrosis, CRT was also up-
regulated during ﬁbrosis progression.9 It is therefore
possible that in organs other than the kidney the ﬁbrotic
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1742Supplemental Figure S1 Relative mRNA amount of human and mouse calreticulin (CRT) transcripts in tubular epithelial cells (TECs) overexpressing CRT,
determined via species-speciﬁc RT-qPCR analysis. Signiﬁcant suppression of the human transcript was observed in the cell line with high overexpression of the
mouse CRT gene. Data represent means  SD of three independent experiments. *P < 0.05 versus control.FLA 5.2.0 DTD  AJPA1470_proof  11 September 2013  4:09 am  EO: AJP13_0026
